| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Andersen PH and Packer JT | Hepatic adenoma. Observations after estrogen withdrawal. | 1976 | Arch Surg | pmid:182106 |
| Boveris A and Stoppani AO | Inhibition of mitochondrial swelling by 19-nor-ethynyltestosterone acetate and other steroids. | 1971 | Arch. Biochem. Biophys. | pmid:4322804 |
| Boveris A and Stoppani AO | Inhibition of electron and energy transfer in mitochondria by 19-nor-ethynyltestosterone acetate. | 1970 | Arch. Biochem. Biophys. | pmid:4322290 |
| Nallani GC et al. | Tissue-specific uptake and bioconcentration of the oral contraceptive norethindrone in two freshwater fishes. | 2012 | Arch. Environ. Contam. Toxicol. | pmid:21710293 |
| Stier G et al. | [Experience in the treatment of metastatic breast carcinoma with norethisterone acetate in a clinical study]. | 1989 | Arch. Geschwulstforsch. | pmid:2655553 |
| Bohnet HG et al. | Effects of synthetic gestagens on serum prolactin and growth hormone secretion in amenorrheic patients. | 1978 | Arch. Gynecol. | pmid:736621 |
| Breckwoldt M et al. | Plasma levels of FSH and LH in patients with gonadal dysgenesis during sequential estrogen and progestogen therapy. | 1980 | Arch. Gynecol. | pmid:6779717 |
| Roll H et al. | [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome]. | 1979 | Arch. Gynecol. | pmid:485482 |
| Ferrero S and Remorgida V | Endometriosis presenting with hemorrhagic ascites. | 2011 | Arch. Gynecol. Obstet. | pmid:21153594 |
| Yildirim G et al. | Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding. | 2006 | Arch. Gynecol. Obstet. | pmid:16315025 |
| Tugrul S et al. | Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects. | 2007 | Arch. Gynecol. Obstet. | pmid:17051405 |
| Petraglia F et al. | Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. | 2012 | Arch. Gynecol. Obstet. | pmid:21681516 |
| Ferrero S et al. | Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. | 2013 | Arch. Gynecol. Obstet. | pmid:23053314 |
| Cano A et al. | The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women. | 2003 | Arch. Gynecol. Obstet. | pmid:14504877 |
| Bingol B et al. | Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women. | 2010 | Arch. Gynecol. Obstet. | pmid:19593578 |
| Lindheimer MD et al. | Oral-contraceptive-induced hypertension after adrenalectomy and hypophysectomy. | 1976 | Arch. Intern. Med. | pmid:962446 |
| DELORIMIER AA et al. | METHYLTESTOSTERONE, RELATED STEROIDS, AND LIVER FUNCTION. | 1965 | Arch. Intern. Med. | pmid:14315662 |
| Wishart J et al. | Treatment of postmenopausal hyperparathyroidism with norethindrone. Long-term effects on forearm mineral content. | 1990 | Arch. Intern. Med. | pmid:2393326 |
| Moses AM and Notman DD | Secondary hyperparathyroidism caused by oral contraceptives. | 1982 | Arch. Intern. Med. | pmid:6274264 |
| Cole M | Strokes in young women using oral contraceptives. | 1967 | Arch. Intern. Med. | pmid:6054589 |
| Horowitz M et al. | Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density. | 1987 | Arch. Intern. Med. | pmid:3827457 |
| Myrup B et al. | Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment. | 1992 | Arch. Intern. Med. | pmid:1332634 |
| Macaraeg PV et al. | Neutrophil alkaline phosphatase activity. Effect of certain oral contraceptive hormones. | 1968 | Arch. Intern. Med. | pmid:4176910 |
| Davidson MH et al. | Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. | 2000 | Arch. Intern. Med. | pmid:11088095 |
| Pasapera AM et al. | In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents. | 1995 | Arch. Med. Res. | pmid:8845651 |
| Oropeza MV et al. | Estrogenic actions of norethisterone and its A-ring reduced metabolites. Induction of in vitro uterine sensitivity to serotonin. | 1994 | Arch. Med. Res. | pmid:7803979 |
| Altshuler JH et al. | Neurological catastrophe related to oral contraceptives. | 1968 | Arch. Neurol. | pmid:5725158 |
| Gamboa ET et al. | Chorea associated with oral contraceptive therapy. | 1971 | Arch. Neurol. | pmid:5571013 |
| Lai FM et al. | Diffuse uterine leiomyomatosis with hemorrhage. | 1991 | Arch. Pathol. Lab. Med. | pmid:1863197 |
| Beliaeva LA et al. | [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)]. | 1982 | Arkh. Patol. | pmid:7082195 |
| Hemelaar M et al. | Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women. | 2006 | Arterioscler. Thromb. Vasc. Biol. | pmid:16645152 |
| Teede HJ et al. | Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. | 2000 | Arterioscler. Thromb. Vasc. Biol. | pmid:10807761 |
| Barton M et al. | Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? | 2007 | Arterioscler. Thromb. Vasc. Biol. | pmid:17634518 |
| Sherwood A et al. | Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. | 2007 | Arterioscler. Thromb. Vasc. Biol. | pmid:17541023 |
| Taskinen MR et al. | Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. | 1996 | Arterioscler. Thromb. Vasc. Biol. | pmid:8857916 |
| Alexandersen P et al. | Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits. | 1998 | Arterioscler. Thromb. Vasc. Biol. | pmid:9633929 |
| Bagdade JD and Subbaiah PV | Atherosclerosis and oral contraceptive use. Serum from oral contraceptive users stimulates growth of arterial smooth muscle cells. | 1982 Mar-Apr | Arteriosclerosis | pmid:7065983 |
| Hansen A et al. | Developments in lupus 2006. | 2007 | Arthritis Res. Ther. | pmid:17634152 |
| Høegh-Andersen P et al. | Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. | 2004 | Arthritis Res. Ther. | pmid:15059281 |
| Jungers P et al. | Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. | 1982 | Arthritis Rheum. | pmid:7092961 |
| Hall GM et al. | Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. | 1995 | Arthritis Rheum. | pmid:7612039 |
| Takenaka T et al. | Judicious usage of estrogen/progesterone for angiodysplasia. | 2005 | Artif Organs | pmid:15644090 |
| Nishino Y and Neumann F | [Estrogenic partial effect of gestagens, in particular that of norethisterone enanthate (author's transl)]. | 1980 | Arzneimittelforschung | pmid:6770875 |
| Gerhards E et al. | Studies of the kinetics and metabolism of 17 beta-heptanoyl-17 alpha-ethinyl-4-oestren-3-one-7-3H (norethisterone enanthate) in humans following intramuscular injection. | 1976 | Arzneimittelforschung | pmid:1036962 |
| Warren RJ and Fotherby K | Metabolism of D- and L-norgestrel in humans. | 1975 | Arzneimittelforschung | pmid:169856 |
| Kulcsár A et al. | Hepatic actions of progestogenic steroids. | 1984 | Arzneimittelforschung | pmid:6542791 |
| Kulcsár A and Kulcsár-Gergely J | Administration of progesterone and progestogens in chronical liver injury. | 1979 | Arzneimittelforschung | pmid:156027 |
| Kulcsár-Gergely J and Kulcsár A | The sexual cycle in rats during progesterone and progestogen treatment. | 1979 | Arzneimittelforschung | pmid:156028 |
| Zeller WJ et al. | Compatibility of hormonal contraceptives in diabetics. Results of a questionnaire survey. | 1974 | Arzneimittelforschung | pmid:4135187 |
| van der Vies J and de Visser J | Endocrinological studies with desogestrel. | 1983 | Arzneimittelforschung | pmid:6221730 |